Cytokines are small signaling proteins that immune cells release to coordinate the body’s response to infection, injury, and disease. Pro-inflammatory cytokines ramp up immune activity, drawing defensive cells to the site of trouble and amplifying the attack on invaders. Anti-inflammatory cytokines do the opposite, dialing the response back down to prevent collateral damage to healthy tissue. The balance between these two forces is not static but shifts constantly in response to cues from both the body and whatever threat it faces, and when that balance tips too far in either direction, serious illness can follow.
How Pro-Inflammatory Cytokines Sound the Alarm
When your body detects a pathogen or tissue injury, certain immune cells release pro-inflammatory cytokines to kickstart the defense. The best-known players include tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). These molecules activate and recruit other immune cells to the site of trouble and help trigger fever, swelling, and increased blood flow, all classic signs of inflammation.1PubMed Central. Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious Diseases: A Comprehensive Review
One of the more immediate effects of TNF-α and IL-1β is that they increase the permeability of blood vessel walls. This lets immune cells and defensive proteins squeeze through the vessel lining and reach infected or damaged tissue faster. Lab studies have shown that TNF-α produces a rapid, dose-dependent increase in endothelial permeability, while IL-1α triggers a similar but slower effect that peaks after about 24 hours.2PubMed. Tumor necrosis factor and interleukin 1 alpha increase vascular endothelial permeability This vascular leakiness is useful during an acute infection, when you need immune reinforcements arriving quickly, but it becomes a problem if the signaling does not stop. When TNF-α and IL-1β persist, they can impair tight-junction proteins that hold endothelial cells together, contributing to barrier breakdown in conditions like uveitis, where vascular leakage in the eye leads to swelling and vision problems.3PubMed. Effects of tumor necrosis factor-α and interleukin-1β on human retinal endothelial cells
IL-1β also drives permeability through a less obvious route: it activates tissue factor, a protein involved in blood clotting, on the surface of endothelial cells. Research using a two-compartment lab model found that IL-1β caused a rapid and marked increase in permeability across cell layers, and that this effect was entirely blocked when tissue factor was neutralized with an antibody.4PubMed Central. Interleukin-1beta induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity The connection between inflammation and clotting is clinically relevant because excessive clotting inside blood vessels is a dangerous feature of severe infections like sepsis.
How Anti-Inflammatory Cytokines Restore Order
If pro-inflammatory cytokines are the alarm, anti-inflammatory cytokines are the all-clear signal. Key members of this group include IL-10, transforming growth factor beta (TGF-β), and IL-22. These molecules suppress excessive immune activation, promote tissue repair, and help the body return to a normal resting state. Without them, every immune response would risk spiraling into organ damage.
Regulatory cytokines work alongside other environmental signals to control how aggressively immune cells behave, both during active infections and under normal resting conditions. Even in the absence of infection, these molecules keep immune cells in check, preventing the spontaneous self-directed attacks that underlie autoimmune diseases.5PubMed Central. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity The system maintains a dynamic balance, continuously adjusting in response to feedback from both the host’s own tissues and any pathogens present.6PubMed Central. Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology
Beyond individual cytokines, the body also produces specialized pro-resolving mediators, lipid-derived molecules that actively promote the winding-down of inflammation and the return to tissue homeostasis. Chronic inflammatory disorders appear to be characterized by deficiencies in these resolution signals, which has made them a focus of research into potential new treatments for persistent inflammatory conditions.7PubMed Central. Specialized pro-resolving mediators as modulators of immune responses
When the Same Cytokine Does Both
One of the more surprising aspects of cytokine biology is that some molecules do not fit neatly into the “pro” or “anti” category. IL-6 is the textbook example. It can drive inflammation or help resolve it, depending on how it signals.
IL-6 uses two different signaling routes. In classical signaling, it binds to a membrane-bound receptor found on only a few cell types, and this pathway tends to support anti-inflammatory and regenerative effects. In trans-signaling, IL-6 binds to a soluble form of its receptor that floats freely in the blood, and this pathway is primarily pro-inflammatory.8PubMed Central. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6 So the same molecule, delivered to the same tissue, can produce opposite effects depending on which receptor form it encounters.9PubMed Central. Classical Signaling and Trans-Signaling Pathways Stimulated by Megalobrama amblycephala IL-6 and IL-6R
This dual nature has real consequences for treatment. Drugs that block IL-6 entirely may suppress harmful inflammation but also shut down its tissue-repair functions. Newer therapeutic strategies aim to selectively block trans-signaling while leaving classical signaling intact, though this remains an active area of development.
The Inflammasome as a Built-In Trigger
Not all pro-inflammatory cytokines are released straight from the cell in their active form. IL-1β and IL-18 both require a processing step before they can do their jobs, and the molecular machine responsible is called the inflammasome. The best-studied version, NLRP3, is a protein complex that assembles inside immune cells when the cell detects danger signals from pathogens or damaged tissue.10PubMed Central. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
Under normal conditions, NLRP3 sits in an inactive form. When triggered, it oligomerizes and activates an enzyme called caspase-1, which cuts the inactive precursors of IL-1β and IL-18 into their mature, functional forms and releases them from the cell.11PubMed Central. Mechanism and Regulation of NLRP3 Inflammasome Activation This same process can also trigger pyroptosis, a form of inflammatory cell death in which the dying cell essentially bursts open, spilling its contents and amplifying the alarm signal to neighboring cells.
The inflammasome acts like a security checkpoint: the cell has to receive the right combination of danger signals before IL-1β and IL-18 are unleashed. When the checkpoint works properly, inflammation is proportionate to the threat. When it misfires, as it appears to in conditions like gout, type 2 diabetes, and some neurodegenerative diseases, chronic low-grade inflammation results from the steady drip of these pro-inflammatory cytokines even when no real pathogen is present.
Decoy Receptors as Natural Brakes
The body does not rely solely on anti-inflammatory cytokines to restrain the immune response. It also deploys decoy receptors, molecules that look like the real thing to a pro-inflammatory cytokine but are incapable of passing the signal along. These decoys bind cytokines with high affinity and specificity, acting as molecular traps that prevent the cytokine from reaching a functional receptor and triggering inflammation.12PubMed. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines
This strategy has been conserved across a broad range of species, suggesting it is a fundamental tool in the immune regulatory toolkit.13PubMed Central. Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation The concept has also been borrowed for drug design: one major class of biologic therapy for rheumatoid arthritis uses a manufactured decoy receptor to soak up TNF-α before it can drive joint inflammation. When decoy receptor function is defective, inflammatory signals go unchecked, and this dysfunction has been implicated in autoimmune conditions where the immune system cannot properly put the brakes on its own activity.14PubMed Central. Decoy Receptors in Autoimmunity: Molecular Guardians and Pathogenic Players in Immune Dysregulation
What a Cytokine Storm Looks Like
The most dramatic failure of cytokine balance is the cytokine storm, an event in which pro-inflammatory cytokine production becomes self-amplifying and spirals out of control. The severity of infections like sepsis is driven by this autoamplifying cascade.15PubMed. Cytokine storm and sepsis disease pathogenesis Rather than a targeted, proportional response, the immune system floods the bloodstream with inflammatory signals that activate immune cells indiscriminately, damaging the body’s own organs in the process.
Sepsis is a life-threatening syndrome defined by this kind of uncontrolled systemic inflammation, in which innate immune hyperactivation drives excessive cytokine release and inflammatory cell death, ultimately leading to multi-organ failure.16PubMed Central. Roles of cytokine storm in sepsis progression: biomarkers, and emerging therapeutic strategies The COVID-19 pandemic brought cytokine storms into public awareness because severe cases frequently involved this pattern: patients deteriorated not simply from the virus itself but from their own immune system’s overreaction. The vascular permeability effects of TNF-α and IL-1β described earlier become especially dangerous during a cytokine storm, as widespread vessel leakiness contributes to fluid accumulation in the lungs and dangerously low blood pressure.
Chronic Disease and Persistent Imbalance
Cytokine storms are acute, dramatic emergencies. But a more common problem, from a public health perspective, is the slow, steady tilt toward pro-inflammatory signaling that underlies many chronic diseases.
In obesity, immune cells accumulate in adipose tissue and shift toward an inflammatory state. Over the past few decades, researchers have recognized that this metabolic inflammation occurs in fat, muscle, liver, gut, the pancreas, and even the brain, contributing to insulin resistance and type 2 diabetes.17PubMed Central. Metabolic Inflammation and Insulin Resistance in Obesity Studies of people with modest obesity have found that TNF-α expression in visceral fat tissue correlates with a standard measure of insulin resistance, even at early stages of metabolic dysfunction.18PLoS ONE. The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction In other words, the inflammatory shift is not just a consequence of advanced disease but something that begins early and may drive the metabolic changes.
Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, offers another clear example. In IBD, the imbalance between pro- and anti-inflammatory cytokines in the gut drives disease progression, tissue damage, and prevents the inflammation from resolving on its own.19PubMed Central. Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease The gut lining, already thin and exposed to a complex microbial environment, is especially vulnerable when inflammatory signaling runs chronically high.
Cytokines in the Brain
The brain has its own resident immune cells, called microglia, that respond to injury and infection by releasing cytokines. Under inflammatory conditions, activated microglia can enter a positive feedback loop, secreting pro-inflammatory mediators that are themselves neurotoxic and worsen existing damage.20Frontiers in Cellular Neuroscience. Microglia at the blood brain barrier in health and disease This matters because the brain is normally protected by the blood-brain barrier, a tightly sealed layer of cells that keeps most blood-borne substances out of neural tissue.
When microglia become activated, though, they can compromise this barrier. Lab models have shown that microglia stimulated by bacterial toxins directly increase the permeability of brain endothelial cells. Blocking TNF-α in these models suppressed the endothelial dysfunction, pointing to that cytokine as a key driver of barrier breakdown.21Frontiers in Cellular Neuroscience. Blood-Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction The interaction between activated microglia and the blood-brain barrier has been implicated in both acute conditions like stroke and slow neurodegenerative diseases like Alzheimer’s.22PubMed Central. Microglia and the Blood-Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions
The Cancer Paradox
Cytokines play an especially complicated role in cancer. On one hand, pro-inflammatory cytokines help the immune system identify and kill tumor cells. On the other hand, chronic inflammation in and around a tumor can actually promote cancer growth, helping tumors evade immune detection and stimulating new blood vessel formation that feeds the tumor.
Several inflammatory mediators, including TNF-α, IL-6, TGF-β, and IL-10, have been shown to participate in both the initiation and progression of cancer.23PubMed Central. Chronic inflammation and cytokines in the tumor microenvironment The tumor microenvironment, the ecosystem of cells and molecules surrounding a tumor, actively manipulates cytokine signaling to its advantage. Tumors can co-opt immune cells into producing signals that suppress the very anti-tumor immune response that should be destroying them. This dual capacity to both suppress and promote cancer progression makes cytokine-based cancer therapy particularly tricky to design, because boosting inflammation might help kill the tumor or might inadvertently fuel it.24PubMed Central. The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
Biologic Therapies That Target Cytokines
The growing understanding of cytokine roles has led to an entire class of drugs called biologics, which are engineered proteins designed to block or mimic specific cytokines. Anti-TNF antibodies are among the most widely prescribed, used to treat rheumatoid arthritis, Crohn’s disease, psoriasis, and several other conditions. Other biologics include recombinant IL-1 receptor antagonists that block IL-1 signaling, anti-IL-6 receptor antibodies, and antibodies targeting the Th17 pathway.25PubMed Central. Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations
These therapies have transformed the management of many chronic inflammatory diseases, but they come with a fundamental trade-off. Systemically blocking a pro-inflammatory cytokine reduces disease-driven inflammation, but it also weakens the immune response to infections. Patients on anti-TNF therapy, for instance, face a higher risk of tuberculosis reactivation and certain fungal infections because TNF-α is essential for containing those pathogens. This is not a side effect that can be engineered away; it reflects the core reality that pro-inflammatory cytokines exist because the body needs them.
The same logic applies throughout cytokine signaling. More than 50 cytokines, growth factors, and hormones funnel their signals through a shared pathway called JAK-STAT, which has itself become a drug target.26PubMed. The regulation of JAKs in cytokine signaling and its breakdown in disease JAK inhibitors, now used in conditions ranging from rheumatoid arthritis to certain blood cancers, can dampen multiple cytokine signals at once, offering broad anti-inflammatory effects but also raising the same infection-susceptibility concerns, sometimes more broadly, because the net is wider.
Inflammaging and the Slow Drift With Age
As people age, the balance between pro- and anti-inflammatory cytokines shifts. The term “inflammaging” describes the low-grade, chronic pro-inflammatory state that develops in older adults even without obvious infection or autoimmune disease. One major contributor is cellular senescence: aged cells stop dividing but do not die. Instead, they adopt what researchers call a senescence-associated secretory phenotype, releasing a steady stream of pro-inflammatory cytokines, chemokines, and tissue-degrading enzymes into surrounding tissue.27PubMed Central. Cellular Senescence and Inflammaging in Age-Related Diseases
This background hum of inflammation is thought to contribute to many age-related diseases, from atherosclerosis to neurodegeneration to type 2 diabetes. It may also partly explain why older adults respond more poorly to infections and vaccines: the immune system, perpetually stimulated at a low level, is less able to mount a sharp, targeted response when a genuine threat appears. Research into drugs that clear senescent cells, sometimes called senolytics, is partly motivated by the hope that removing these cytokine-spewing cells might lower the inflammatory baseline and improve healthspan.
Everyday Factors That Shift the Balance
You do not need to be sick or aging to see your cytokine balance shift. Several everyday factors modulate the balance in ways that are increasingly well documented.
Exercise is one of the more reliable levers. A meta-analysis of resistance exercise studies found a small to moderate increase in IL-6 and a moderate to large increase in IL-1 receptor antagonist (IL-1ra, an anti-inflammatory molecule) following a workout, while the anti-inflammatory cytokine IL-10 did not change significantly.28bioRxiv. Acute resistance exercise-induced changes in IL-6, IL-10, and IL-1ra in healthy adults: a systematic review and meta-analysis The temporary IL-6 spike during exercise is actually part of a beneficial pattern: muscle-derived IL-6 appears to trigger anti-inflammatory responses downstream, which is one reason regular exercise is associated with reduced chronic inflammation over time despite producing short-term inflammatory signals.
Sleep and circadian rhythms exert a strong influence as well. In human blood, pro-inflammatory cytokines like IL-12 peak during the nighttime sleep period, while anti-inflammatory cytokines like IL-10 peak during the day. The circadian system and sleep work together to produce this pattern, creating an endocrine environment at night that favors immune activation and pro-inflammatory signaling.29PubMed. Effects of sleep and circadian rhythm on the human immune system Animal studies have shown that the induction of pro-inflammatory cytokines like IL-6 is far greater when the immune system is challenged at the transition into the active period compared to the rest period, which helps explain why immune defense is stronger at certain times of day but also why the risk of an overblown inflammatory response, like sepsis, can vary by time of challenge.30Immunity. The Circadian Control of Immunity – Section: The Molecular Clock Controls Antibacterial Host Defense, Sepsis, and Inflammation Chronic sleep deprivation disrupts these rhythms and is consistently linked to higher baseline levels of inflammatory markers.
Diet influences cytokine balance through several routes. The gut microbiota, the trillions of microbes living in your intestines, produce metabolites like short-chain fatty acids that mediate crosstalk between gut cells and immune cells, helping maintain intestinal homeostasis and inhibit inflammation.31PubMed Central. Gut Microbiota and Immune System Interactions A diet rich in fiber feeds these beneficial microbes, while highly processed diets tend to reduce microbial diversity and shift the immune environment toward inflammation. Polyphenols, compounds found in foods like berries, tea, olive oil, and dark chocolate, have been shown to suppress pro-inflammatory cytokine production by interfering with key inflammatory signaling pathways, and they can also suppress the expression of genes that drive inflammation.32PubMed Central. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols33PubMed. Dietary polyphenols suppress chronic inflammation by modulation of multiple inflammation-associated cell signaling pathways
None of these lifestyle factors are magic bullets. But they consistently nudge the cytokine balance in the same direction: toward less chronic background inflammation and a more proportionate immune response when one is actually needed. Given how many diseases trace back to a cytokine balance tipped too far toward inflammation for too long, that nudge has outsized practical relevance.